Genome-wide Association Study Meta-analysis of Neurofilament light (NfL) levels in blood reveals novel loci related to neurodegeneration
Ahmad, S.; Imtiaz, M. A.; Mishra, A.; Wang, R.; Herrera-Rivero, M.; Bis, J. C.; Fornage, M.; Roshchupkin, G.; Hofer, E.; Logue, M.; Longstreth, W.; Xia, R.; Bouteloup, V.; Mosley, T.; Launer, L.; Khalil, M.; Kuhle, J.; Rissman, R. A.; Chene, G.; Dufouil, C.; Djousse, L.; Lyons, M. J.; Mukamal, K. J.; Kremen, W. S.; Franz, C. E.; Schmidt, R.; Debette, S.; Breteler, M. M. B.; Berger, K.; Yang, Q.; Seshadri, S.; Aziz, N. A.; Ghanbari, M.; Ikram, M. A.
Show abstract
BackgroundNeurofilament light chain (NfL) levels in circulation have been established as a sensitive biomarker of neuro-axonal damage across a range of neurodegenerative disorders. Elucidation of the genetic architecture of blood NfL levels and its genetic correlation with neurological traits could therefore provide new insights into shared molecular mechanisms underlying neurodegenerative disorders. MethodsTo identify the genetic variations underlying blood NfL levels, we conducted an ancestry-specific meta-analyses of genome-wide association studies (GWAS) based on 18,532 participants from 11 cohorts of European and 1142 participants (3 cohorts) of African-American ancestry. In the post-GWAS analyses, we performed expression quantitative trait loci (eQTL) analysis, LD-regression, and genetic risk score (GRS) association analysis with neurological traits. ResultsIn the European ancestry GWAS meta-analysis, we identified two genome-wide significant (P < 5x10-8) loci at 16p12 (UMOD), and 17q24 (SLC39A11). In the African-American ancestry GWAS meta-analysis, we identified three novel loci at 1q43 (FMN2), 12q14, and 12q21. Genetic correlation based on the European ancestry meta-analysis with neurological traits showed a strong genetic correlation of NfL with Alzheimers disease(AD) (rg = 0.32, P = 1.74x10-6), total-tau (rg = 2.01, P = 1.03x10-6), amyloid-beta (A{beta})-40 (rg = 0.80, P = 6.92x10-6), and A{beta}-42 (rg = 1.03, P = 4.39x10-5). A higher genetic risk score based on NfL-associated genetic variants was also related to increased plasma levels of total-tau (P = 1.97x10-4), A{beta}-40 (P = 2.24x10-5), A{beta}-42 (P = 2.92x10-4) in the Rotterdam Study. ConclusionThis large-scale GWAS meta-analysis revealed multiple novel genetic loci of NFL levels in blood in participants from European and African-American ancestry. Significant genetic correlation of genes underlying NfL with AD, A{beta}-42, and total-tau may indicate a common underlying pathway of neurodegeneration.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genetic perturbations of disease risk genes in mice capture transcriptomic signatures of late-onset Alzheimer’s disease 94%
- Interrogating the plasma proteome of repetitive head impact exposure and chronic traumatic encephalopathy 94%
- Deciphering cellular transcriptional alterations in Alzheimer's disease brains 94%
Similar papers in this journal
- Integrative Brain Transcriptome Analysis Links Complement Component 4 and HSPA2 to the APOE ε2 Protective Effect in Alzheimer Disease 95%
- Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival 95%
- African Ancestry GWAS of Dementia in a Large Military Cohort Identifies Significant Risk Loci 95%
Similar papers in this journal
- Physical activity and risk of Alzheimer’s disease: a two-sample Mendelian randomization study 92%
- Serum NfL in spinocerebellar ataxia type 1 is increased already at the preataxic stage, correlating with proximity to clinical onset 92%
- Novel associations of BST1 and LAMP3 with rapid eye movement sleep behavior disorder 91%
Similar papers in this journal
- TREM2 Risk Variants with Alzheimer’s Disease Differ in Rate of Cognitive Decline 95%
- Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer's disease 94%
- Polygenic effects on the risk of Alzheimer’s disease in the Japanese population 94%